Cargando…
Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors
Kv1.5 potassium channel, encoded by KCNA5, is a promising target for the treatment of atrial fibrillation, one of the common arrhythmia. A new series of arylmethylpiperidines derivatives based on DDO-02001 were synthesised and evaluated for their ability to inhibit Kv1.5 channel. Among them, compoun...
Autores principales: | Zhao, Lingyue, Yang, Qian, Tang, Yiqun, You, Qidong, Guo, Xiaoke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757610/ https://www.ncbi.nlm.nih.gov/pubmed/35012386 http://dx.doi.org/10.1080/14756366.2021.2018683 |
Ejemplares similares
-
Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel
por: Li, Kai, et al.
Publicado: (2017) -
Chemical and biological study of aplysiatoxin derivatives showing inhibition of potassium channel Kv1.5
por: Tang, Yang-Hua, et al.
Publicado: (2019) -
Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5
por: Zhao, Zefeng, et al.
Publicado: (2019) -
The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state
por: Lee, Hyang Mi, et al.
Publicado: (2022) -
Potassium-dependent Changes in the Conformation of the Kv2.1 Potassium Channel Pore
por: Immke, David, et al.
Publicado: (1999)